Financial News
All News about Royalty Pharma Plc Cl A
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/12/Interest-Rate-And-Dividend-Yield-Concept.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Looking Into Royalty Pharma's Recent Short Interest
April 04, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/28/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-DrugPharm-44-adobe.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2024/05/23/CYTK.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2024/04/dividend-stocks1600-4.png)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
From Royalty Pharma plc
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Reports First Quarter 2024 Results
May 09, 2024
From Royalty Pharma plc
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
From Royalty Pharma plc
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2024/05/02/pharmaceutical.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Declares Second Quarter 2024 Dividend
April 17, 2024
From Royalty Pharma plc
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2020/07/pharma-stocks.jpg)
![](https://investorplace.com/wp-content/uploads/2014/07/eccentric_millionaire_billionaire_luxury.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/radar_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
From Royalty Pharma plc
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/765200/oil-rig-workers-talking.jpg)
![](https://ml.globenewswire.com/media/d605b3b0-7ba0-46e1-a2d4-439ca98694f8/small/logo-jpg.jpg)
Royalty Pharma Reports Q4 and Full Year 2023 Results
February 15, 2024
From Royalty Pharma plc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.